SRF Limited announced its un-audited financial results for the quarter and nine months ended December 31, 2025. The company reported a consolidated Profit After Tax (PAT) of ₹432.7 crore for Q3 FY26, marking a significant increase of 59.6% compared to ₹271.1 crore in the same period last year. Gross Operating Revenue for the quarter rose by 6.3% to ₹3,712.5 crore from ₹3,491.3 crore in Q3 FY25.

For the nine months ended December 31, 2025 (9M FY26), PAT grew by 72.9% to ₹1,253.2 crore, up from ₹724.7 crore in 9M FY25. Gross Operating Revenue for the nine-month period increased by 7.6% to ₹11,171.3 crore.

The Chemicals business was a key driver, with segment revenues growing by 22.0% to ₹1,824.8 crore and EBIT increasing by 36.4% to ₹496.0 crore in Q3 FY26. The company's board also approved a capital expenditure of ₹180 crore for a new Pharma Intermediates Plant at Dahej. The Performance Films & Foil business saw a slight decline in revenue by 3.1% to ₹1,342.3 crore, though EBIT improved by 4.9% to ₹94.8 crore. The Technical Textiles business experienced an 11.0% drop in revenue to ₹453.6 crore, with EBIT falling by 23.7% to ₹44.9 crore, impacted by margin pressures and cheaper imports.

The company highlighted its market leadership across various segments, including Specialty Chemicals, Fluorochemicals, Performance Films & Foil, and Technical Textiles. SRF is focusing on building high-end value-added products, nurturing innovation through R&D, and increasing its focus on ESG initiatives.